← Leaderboards
Amy E Dezern
Johns Hopkins University
$1,824,012
Attributed
$2,847,449
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $409.4K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,847,449 · 4
By mechanism
R01$1,637,500 · 1
K23$636,928 · 1
R56$409,375 · 1
R03$163,646 · 1
Top collaborators
- William Brian Dalton5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert A Brodsky$10,132,414
- Jason Eli Farrar$2,896,875
- James F Casella$7,723,944
- Saul J Sharkis$10,418,412
- Lukasz Pawel Gondek$3,151,101
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectResourcesDysmyelopoietic SyndromesResponseNovel Therapeutic InterventionPublicationsClinical ResearchMediatingGeneticBone MarrowMarrowBiologicalPancytopeniaCellsSamplingMutationDisease PhenotypeHematopoiesisRat Piga ProteinRefractoryNovel StrategiesDiagnosisMorbidity - Disease RateAplastic Anemia
Grant awards (11)
Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS$409,375
R01 · FY2025 · HL
Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS$409,375
R01 · FY2024 · HL
Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS$409,375
R01 · FY2023 · HL
Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS$409,375
R01 · FY2022 · HL
Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS$409,375
R56 · FY2021 · HL
Advancing Diagnostics and Therapeutics in Bone Marrow Failure$81,875
R03 · FY2018 · HL · contact PI
Advancing Diagnostics and Therapeutics in Bone Marrow Failure$177,120
K23 · FY2017 · HL · contact PI
Advancing Diagnostics and Therapeutics in Bone Marrow Failure$81,771
R03 · FY2017 · HL · contact PI
Advancing Diagnostics and Therapeutics in Bone Marrow Failure$177,120
K23 · FY2016 · HL · contact PI
Advancing Diagnostics and Therapeutics in Bone Marrow Failure$141,344
K23 · FY2015 · HL · contact PI
Advancing Diagnostics and Therapeutics in Bone Marrow Failure$141,344
K23 · FY2014 · HL · contact PI